Pilot Investigation on the Combined Use of Established Clinical Criteria and Systems Biology for Progressive Pulmonary Fibrosis
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Analysis of lung biopsies by system biology techniques.
研究概览
简要总结
RESOLVE's objective is to identify and characterize validated molecular targets capable of shifting primary organ repair towards fibroproliferative wound healing.
Work package 2 (WP2) of RESOLVE includes the clinical study protocols within the RESOLVE system evaluating different forms of pulmonary repair in humans ranging from normal repair over mainly inflammatory to predominantly fibroproliferative repair.
Hypothesis
Fibrosis of the lung is an aberrant and intensified form of wound healing. It is the result of an unresolved disturbance of both initiation and control of repair which is partly age-related. As a result of the relentlessly activated wound healing reaction, mechanisms of inflammation largely representing the condition of chronic inflammation within the peripheral bronchial tree will aggravate this abnormal form of repair.
A systematic comparison of the molecular pathology of fibrotic repair representing
- Varying intensity of fibrosis related to the pathology of usual interstitial pneumonia (UIP),
- Varying inflammatory mechanisms (UIP vs. Hypersensitivity pneumonitis [HP], acute and chronic), and
- Varying stages of age (Normal pulmonary repair in young and old individuals vs. acute/chronic HP vs. UIP) will be able to
- identify molecules capable of shifting regular repair towards fibroproliferative repair and
- elucidate their interrelationship with other molecules forming coordinated yet misdirected metabolic responses characteristic for fibroproliferative repair.
详细描述
Background
After reaching adulthood, the organs of the human body preserve their shape and function over a long period, making directed repair one of the most important mechanisms throughout lifetime. Regular wound healing after an injury consists of a well-ordered sequence of overlapping phases: inflammation, formation of supportive new tissue, re-epithelization and final regeneration of epithelial and endothelial lining cells, and essentially repeats the complex process of organ development. In young adults, damage to an organ is frequently answered by fully regenerative wound healing repeating mechanisms of embryonic organ growth called "primary" wound healing. Repeated damage in younger individuals may cause "secondary" wound healing in form of scar formation serving as a rescue program to maintain surface integrity once epithelial and/or endothelial reorganization has failed.
Organ failure in the ageing organism, however, is different and essentially represents the loss of its capacity to achieve an orderly reactivation of organ development. This different quality of wound healing consists of a combination of chronic inflammation and fibroproliferative, non-regenerative repair. Its pathology refers to a large group of diseases involving every organ of the human body.
In the lung, its most prominent form is characterized by a well-defined histopathology named usual interstitial pneumonia (UIP). Unfortunately, this histopathology, while identifying a particularly aggressive phenotype of the fibroproliferative repair response itself, does not allow for an unambiguous clinical diagnosis, as the UIP "pattern" may be found in different fibrotic diseases of the lung, such as hypersensitivity pneumonitis (HP), especially in its chronic form.
In addition, various mechanisms of inflammation which are partly related to the wound healing response itself, may profoundly intensify the aberrant wound healing response. As a result, the mechanisms leading to this condition and maintaining its characteristic clinical appearance are unknown.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 90 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Analysis of lung biopsies by system biology techniques.
时间窗: Two measurements within 1 year.
次要结局
未报告次要终点
研究者
Rolf Ziesche
Associated Professor of Medicine
Medical University of Vienna
